{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:20:25Z","timestamp":1759962025635},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.patbio.2009.05.001","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T11:10:58Z","timestamp":1257592258000},"page":"281-285","source":"Crossref","is-referenced-by-count":3,"title":["R\u00e9sistance \u00e0 la prot\u00e9ine C activ\u00e9e et facteur V Leiden\u00a0: int\u00e9r\u00eat clinique"],"prefix":"10.1016","volume":"59","author":[{"given":"S.","family":"Guermazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Znazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2009.05.001_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.patbio.2009.05.001_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.patbio.2009.05.001_bib3","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","article-title":"Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa","volume":"269","author":"Shen","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.patbio.2009.05.001_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-0038-1653853","article-title":"Influence of factor V and factor Va on APC-induced cleavage of human factor VIII","volume":"73","author":"Varadi","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0038-1649818","article-title":"Acquired activated protein C resistance in patients with lupus anticoagulants","volume":"74","author":"Ehrenforth","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1055\/s-0038-1649904","article-title":"Lowered APC sensitivity ratio related to increased factor VIII clotting activity","volume":"74","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2141.1995.tb05610.x","article-title":"Development of resistance to activated protein C during pregnancy","volume":"90","author":"Cumming","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2009.05.001_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2009.05.001_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1995.tb05323.x","article-title":"Resistance to activated protein C in healthy women taking oral contraceptives","volume":"91","author":"Olivieri","year":"1995","journal-title":"Br J Hematol"},{"key":"10.1016\/j.patbio.2009.05.001_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0140-6736(94)90673-4","article-title":"Modified test for activated protein C resistance","volume":"344","author":"Jorquera","year":"1994","journal-title":"Lancet"},{"issue":"8938","key":"10.1016\/j.patbio.2009.05.001_bib11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0140-6736(94)90494-4","article-title":"Modified APC resistance assay for patients on oral anticoagulants","volume":"344","author":"Trossa\u00ebrt","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2009.05.001_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000073574","article-title":"Laboratory diagnosis of thrombophilic states: where do we stand?","volume":"32","author":"Tripodi","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.patbio.2009.05.001_bib13","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2001.02981.x","article-title":"Investigation and management of heritable thrombophilia. Guideline","volume":"114","author":"Walker","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2009.05.001_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","article-title":"Cambridge: a new mutation (Arg306\u2192Thr) associated with resistance to activated protein C","volume":"91","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","article-title":"A novel mutation of Arg306 of factor V gene in Hong Kong Chinese","volume":"91","author":"Chan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib17","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Test de r\u00e9sistance \u00e0 la prot\u00e9ine C activ\u00e9e. Recherche de la mutation Facteur V Leiden. Recherche de la mutation G20210A de la prothrombine. Septembre 2006. T\u00e9l\u00e9chargeable sur le site\u00a0: www.has-sante.fr."},{"key":"10.1016\/j.patbio.2009.05.001_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2009.05.001_bib19","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2005-12-5158","article-title":"Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago","volume":"107","author":"Zivelin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"De Visser","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1309\/QCUUNRMVJY8MWPPL","article-title":"Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden","volume":"119","author":"Graf","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.patbio.2009.05.001_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(00)02476-4","article-title":"Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism","volume":"356","author":"Bounameaux","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2009.05.001_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.10234","article-title":"The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies","volume":"92","author":"Marchiori","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2009.05.001_bib24","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1538-7836.2008.03173.x","article-title":"Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation","volume":"6","author":"Prandoni","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V90.4.1552","article-title":"A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype","volume":"90","author":"Bernardi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2009.05.001_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2009.05.001_bib27","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/archneur.61.11.1652","article-title":"Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls","volume":"61","author":"Casas","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.patbio.2009.05.001_bib28","first-page":"331","article-title":"Inherited thrombophilia and arterial diseases","volume":"3","author":"Robert-Ebadi","year":"2007","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.patbio.2009.05.001_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2009.05.001_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1160\/TH08-01-0009","article-title":"Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates","volume":"99","author":"Gieseler","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2007.02823.x","article-title":"Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis","volume":"6","author":"Dentali","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archinte.164.5.558","article-title":"Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis","volume":"164","author":"Kovalevsky","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.patbio.2009.05.001_bib33","doi-asserted-by":"crossref","first-page":"1603-0","DOI":"10.1111\/j.1538-7836.2005.01417.x","article-title":"Thrombophilia and pregnancy outcomes","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2009.05.001_bib35","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1538-7836.2008.03134.x","article-title":"Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis","volume":"6","author":"Dudding","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1538-7836.2008.03229.x","article-title":"Inherited thrombophilias and unexplained pregnancy loss: an incident case control study","volume":"7","author":"Pasquier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH07-05-0373","article-title":"Thrombophilias and adverse pregnancy outcome \u2013 A confounded problem!","volume":"99","author":"Kist","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1538-7836.2006.01714.x","article-title":"Activated protein C resistance \u2013 in the absence of factor V Leiden \u2013 and pregnancy","volume":"4","author":"Lindqvist","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2009.05.001_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/16.5.961","article-title":"Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage","volume":"16","author":"Rai","year":"2001","journal-title":"Hum Reprod"},{"issue":"3 Suppl.","key":"10.1016\/j.patbio.2009.05.001_bib40","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811409001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811409001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T13:02:26Z","timestamp":1685192546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811409001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0369811409001011"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2009.05.001","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}